Efficacy of azithromycin in preventing pulmonary abscesses in foals

Vet J. 2009 Feb;179(2):301-3. doi: 10.1016/j.tvjl.2007.10.002. Epub 2007 Nov 26.

Abstract

The prophylactic application of azithromycin to prevent pulmonary abscesses in foals was evaluated on a stud with endemic Rhodococcus equi pneumonia. Forty-five foals served as untreated controls in two groups. Twenty-five foals were given azithromycin (10mg/kg) orally once daily for 4 weeks. The foals were examined once a week from birth to the age of 5 months. If clinical signs or leucocytosis were noted and pulmonary sonographic findings (diameter >10 mm) were observed, the diagnosis of abscessing pneumonia was made. The prevalence of pulmonary abscesses was similar in the control groups (31/45 foals), and in the azithromycin group (15/25 foals), but the foals in the azithromycin group were affected significantly later (median: day 83, range 67-123 days) (control groups: day 54, range 52-82; and 46, range 28-86 days). It was concluded that the application of azithromycin for 28 days post-natally does not reduce the prevalence of pulmonary abscesses in foals on a stud with endemic pneumonia.

MeSH terms

  • Animals
  • Animals, Newborn
  • Anti-Bacterial Agents / therapeutic use*
  • Azithromycin / therapeutic use*
  • Female
  • Horse Diseases / prevention & control*
  • Horses
  • Lung Abscess / prevention & control
  • Lung Abscess / veterinary*
  • Male
  • Pneumonia, Bacterial / prevention & control
  • Pneumonia, Bacterial / veterinary*
  • Random Allocation
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Azithromycin